SKI Market

Indian Indices

Nifty

25,986.00 -46.20
(-0.18%)

Sensex

85,106.81 -31.46
( -0.04%)

Bank Nifty

59,348.25 74.45
( 0.13%)

Nifty IT

37,825.25 284.00
( 0.76%)

Global Indices

Nasdaq

47,501.07 190.74
(0.40%)

Dow Jones

6,850.51 16.88
(0.25%)

Hang Seng

49,986.70 683.25
(1.39%)

Nikkei 225

9,708.56 6.76
(0.07%)

Forex

USD-INR

89.54 0.20
(0.23%)

EUR-INR

103.99 0.41
(0.39%)

GBP-INR

118.45 0.28
(0.24%)

JPY-INR

0.58 0.00
(0.76%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

330.3875196

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

34.03

32340.21

EPS(TTM)

Face Value()

Div & Yield %

76.07

1.09

Back

Uflex reports consolidated net profit of Rs 26.91 crore in the September 2025 quarter

Nov 14,2025

Net profit of Uflex reported to Rs 26.91 crore in the quarter ended September 2025 as against net loss of Rs 64.62 crore during the previous quarter ended September 2024. Sales declined 0.96% to Rs 3744.63 crore in the quarter ended September 2025 as against Rs 3781.03 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	3744.63	3781.03	-1
OPM %	10.32	10.38	-
PBDT	227.19	234.79	-3
PBT	37.78	61.64	-39
NP	26.91	-64.62	LP

25,986.00 -46.20 (-0.18%)

85,106.81 -31.46 ( -0.04%)

59,348.25 74.45 ( 0.13%)

37,825.25 284.00 ( 0.76%)

47,501.07 190.74 (0.40%)

6,850.51 16.88 (0.25%)

49,986.70 683.25 (1.39%)

9,708.56 6.76 (0.07%)

89.54 0.20 (0.23%)

103.99 0.41 (0.39%)

118.45 0.28 (0.24%)

0.58 0.00 (0.76%)